ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,179,208 | +36.9% | 12,593 | +30.5% | 0.00% | +100.0% |
Q2 2023 | $861,446 | -12.4% | 9,652 | +5.3% | 0.00% | 0.0% |
Q1 2023 | $982,994 | -14.1% | 9,168 | -2.2% | 0.00% | -50.0% |
Q4 2022 | $1,144,728 | +26.2% | 9,373 | +6.7% | 0.00% | +100.0% |
Q3 2022 | $907,000 | +17.6% | 8,787 | +6.0% | 0.00% | 0.0% |
Q2 2022 | $771,000 | -20.7% | 8,290 | +0.1% | 0.00% | 0.0% |
Q1 2022 | $972,000 | -14.4% | 8,278 | -2.0% | 0.00% | -50.0% |
Q4 2021 | $1,136,000 | -4.9% | 8,443 | +12.7% | 0.00% | 0.0% |
Q3 2021 | $1,194,000 | +39.0% | 7,489 | +14.7% | 0.00% | +100.0% |
Q2 2021 | $859,000 | +0.7% | 6,527 | -1.3% | 0.00% | 0.0% |
Q1 2021 | $853,000 | -23.2% | 6,616 | -0.6% | 0.00% | -50.0% |
Q4 2020 | $1,110,000 | +7.1% | 6,658 | -0.8% | 0.00% | 0.0% |
Q3 2020 | $1,036,000 | +8.7% | 6,714 | +4.2% | 0.00% | 0.0% |
Q2 2020 | $953,000 | +25.1% | 6,446 | -4.9% | 0.00% | 0.0% |
Q1 2020 | $762,000 | -18.3% | 6,781 | +1.0% | 0.00% | 0.0% |
Q4 2019 | $933,000 | +129.2% | 6,712 | +59.7% | 0.00% | +100.0% |
Q3 2019 | $407,000 | +38.0% | 4,203 | +62.5% | 0.00% | 0.0% |
Q2 2019 | $295,000 | -8.7% | 2,587 | -5.4% | 0.00% | 0.0% |
Q1 2019 | $323,000 | – | 2,734 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |